| 1 |
Ranibizumab for Diabetic Macular Edema
Quan Dong Nguyen, David M. Brown, Dennis M. Marcus et al. · Ophthalmology
|
11 Feb 2012 |
1,625 |
| 2 |
Long-term Outcomes of Ranibizumab Therapy for Diabetic Macular Edema: The 36-Month Results from Two Phase III Trials
David M. Brown, Quan Dong Nguyen, Dennis M. Marcus et al. · Ophthalmology
Open access |
22 May 2013 |
831 |
| 3 |
C5 Inhibitor Avacincaptad Pegol for Geographic Atrophy Due to Age-Related Macular Degeneration
Glenn J. Jaffe, Keith Westby, Karl G. Csaky et al. · Ophthalmology
Open access |
Sep 2020 |
474 |
| 4 |
Efficacy and safety of avacincaptad pegol in patients with geographic atrophy (GATHER2): 12-month results from a randomised, double-masked, phase 3 trial
Arshad M. Khanani et al. · The Lancet
Open access226 authors |
8 Sep 2023 |
364 |
| 5 |
Simultaneous Inhibition of Angiopoietin-2 and Vascular Endothelial Growth Factor-A with Faricimab in Diabetic Macular Edema
Jayashree Sahni, Sunil S. Patel, Pravin U. Dugel et al. · Ophthalmology
Open access |
21 Mar 2019 |
290 |
| 6 |
Efficacy of Every Four Monthly and Quarterly Dosing of Faricimab vs Ranibizumab in Neovascular Age-Related Macular Degeneration
Arshad M. Khanani, Sunil S. Patel, Philip J. Ferrone et al. · JAMA Ophthalmology
Open access |
30 Jul 2020 |
185 |
| 7 |
Avacincaptad pegol for geographic atrophy secondary to age-related macular degeneration: 18-month findings from the GATHER1 trial
Sunil S. Patel, David R. Lally, Jason Hsu et al. · Eye
Open access |
24 Mar 2023 |
144 |
| 8 |
Safety and Efficacy of Different Doses and Regimens of Faricimab vs Ranibizumab in Neovascular Age-Related Macular Degeneration
Jayashree Sahni, Pravin U. Dugel, Sunil S. Patel et al. · JAMA Ophthalmology
Open access |
30 Jul 2020 |
130 |
| 9 |
A multicenter, 12-month randomized study comparing dexamethasone intravitreal implant with ranibizumab in patients with diabetic macular edema
David Callanan, Anat Loewenstein, Sunil S. Patel et al. · Graefe s Archive for Clinical and Experimental Ophthalmology
|
8 Sep 2016 |
106 |
| 10 |
Double-Masked, Randomized, Phase 2 Evaluation of Abicipar Pegol (an Anti-VEGF DARPin Therapeutic) in Neovascular Age-Related Macular Degeneration
David Callanan, Derek Y. Kunimoto, Raj K. Maturi et al. · Journal of Ocular Pharmacology and Therapeutics
Open access |
9 Nov 2018 |
74 |
| 11 |
PHASE 2 STUDY OF THE SAFETY AND EFFICACY OF BRIMONIDINE DRUG DELIVERY SYSTEM (BRIMO DDS) GENERATION 1 IN PATIENTS WITH GEOGRAPHIC ATROPHY SECONDARY TO AGE-RELATED MACULAR DEGENERATION
Baruch D. Kuppermann, Sunil S. Patel, David S. Boyer et al. · Retina
Open access |
3 Mar 2020 |
66 |
| 12 |
Suprachoroidal CLS-TA plus Intravitreal Aflibercept for Diabetic Macular Edema
Mark Barakat, Charles C. Wykoff, Víctor H. González et al. · Ophthalmology Retina
Open access |
20 Aug 2020 |
57 |
| 13 |
Classification of dementia patients by a WAIS profile related to central cholinergic deficiencies
Samuel D. Brinkman, P Braun · Journal of Clinical and Experimental Neuropsychology
|
Nov 1984 |
51 |
| 14 |
EPIRETINAL MACULAR MEMBRANES IN EYES WITH ATTACHED POSTERIOR CORTICAL VITREOUS
Todd W. Heilskov, Stephen J. Massicotte, James C. Folk · Retina
|
1996 |
40 |
| 15 |
Randomized Phase IIb Study of Brimonidine Drug Delivery System Generation 2 for Geographic Atrophy in Age-Related Macular Degeneration
William R. Freeman et al. · Ophthalmology Retina
Open access |
9 Mar 2023 |
25 |
| 16 |
Utility Measures of Health-Related Quality of Life in Patients Treated for Benign Paroxysmal Positional Vertigo
Richard A. Roberts, Harvey B. Abrams, Melanie K. Sembach et al. · Ear and Hearing
|
21 May 2009 |
23 |
| 17 |
Phase I DAVIO Trial: EYP-1901 Bioerodible, Sustained-Delivery Vorolanib Insert in Patients With Wet Age-Related Macular Degeneration
Sunil S. Patel, Philip P. Storey, Mark Barakat et al. · Ophthalmology Science
Open access |
9 Apr 2024 |
19 |
| 18 |
Aqueous humour interleukin-6 and vision outcomes with anti-vascular endothelial growth factor therapy
Yasir Jamal Sepah et al. · Eye
Open access129 authors |
15 Apr 2024 |
16 |
| 19 |
Impact of Modifying Abicipar Manufacturing Process in Patients with Neovascular Age-Related Macular Degeneration: MAPLE Study Results
David Callanan, Rahul N. Khurana, Raj K. Maturi et al. · Clinical ophthalmology
Open access |
May 2023 |
12 |
| 20 |
Multiple Evanescent White Dot Syndrome Developing Three Days following Administration of mRNA-1273 Booster Vaccine: Case Report
Rashed Alhabshan, David A. Scales · Case Reports in Ophthalmology
Open access |
18 Jul 2022 |
10 |
| 21 |
PALEOECOLOGY OF THE GADDIS SITE IN THE UPPER CRETACEOUS AGUJA FORMATION, TERLINGUA, TEXAS
Homer Montgomery, Scott Clark · Palaios
|
Jul 2016 |
9 |
| 22 |
Patient-, Caregiver-, and Eye Care Professional-reported Burden of Geographic Atrophy Secondary to Age-related Macular Degeneration
Rishi P. Singh, Sunil S. Patel, Jared S. Nielsen et al. · American Journal of Ophthalmic Clinical Trials
Open access |
5 Apr 2019 |
8 |
| 23 |
Avacincaptad Pegol for Geographic Atrophy Secondary to Age-Related Macular Degeneration
Arshad M. Khanani et al. · Ophthalmology
Open access219 authors |
16 Dec 2025 |
7 |
| 24 |
Randomized Trials Comparing Inferior Turbinoplasty Techniques for Nasal Obstruction: A Meta‐analysis
Macario Camacho, Yoseph A. Kram, Forrest D. Craig et al. · Otolaryngology
Open access |
9 May 2025 |
5 |
| 25 |
Safety and tolerability of avacincaptad pegol in combination with ranibizumab in treatment-naïve patients with neovascular age-related macular degeneration: results from a phase 1 and phase 2a study
Sunil S Patel, David S Boyer, Anat Loewenstein et al. · BMJ Open Ophthalmology
Open access |
3 Feb 2026 |
1 |
| 26 |
ONL1204 for the Treatment of Geographic Atrophy: Phase Ib Study Evaluating Safety, Tolerability, and Efficacy
David M Kleinman, Charles C. Wykoff, Durga S. Borkar et al. · Ophthalmology Science
Open access |
4 Oct 2025 |
1 |
| 27 |
Automated Deep Learning-Based 3D-to-2D Segmentation of Geographic Atrophy in Optical Coherence Tomography Data
Hasenin Al-khersan, Jonathan D. Oakley, Daniel B. Russakoff et al. · medRxiv
PreprintOpen access |
7 Jul 2025 |
1 |
| 28 |
Anti-VEGF/anti-angiopoietin-2 bispecific antibody RG7716 in diabetic macular edema: complete 36-week results from the phase 2, multicenter, randomized, active treatment-controlled BOULEVARD clinical trial
Sunil S. Patel, Jayashree Sahni, Shamil Sadikhov et al. · Investigative Ophthalmology & Visual Science
Open access |
13 Jul 2018 |
1 |
| 29 |
Primary Retinal Vasculitis Vs Eales' Disease
Courtney M. Crawford · International Journal of open Access Ophthalmology
Open access |
30 Sep 2016 |
1 |
| 30 |
Cost Analysis of Aflibercept 8 mg Versus Aflibercept 2 mg for the Treatment of Diabetic Macular Edema in the PHOTON Trial
Céline Chaaya, Stephanie Zhang, Samantha E. Hoffman et al. · Journal of VitreoRetinal Diseases
Open access |
21 Jul 2026 |
0 |
| 31 |
A randomized, active-controlled clinical trial of fluocinolone acetonide 0.19 mg intravitreal implant for diabetic macular edema: Reductions in injection treatment burden – results from the NEW DAY study
Christopher D. Riemann, Michael Singer, Charles C. Wykoff et al. · German Medical Science (German Research Foundation)
Conference paperOpen access |
17 Jun 2026 |
0 |
| 32 |
Safety and Biological Activity of Intravitreal OGX110, a CXCR3 Agonist, in Persistent Neovascular Age-Related Macular Degeneration: A Phase I Dose-Escalation Study
Alan Wells, David Boyer, Roger Goldberg et al. · medRxiv
PreprintOpen access |
30 May 2026 |
0 |
| 33 |
Biomarker Testing Rates and Patterns in Patients With Metastatic Non–Small Cell Lung Cancer: A Prospective, Observational Study in Community Practices
Makenzi Evangelist, Bo Wang, James E. Butrynski et al. · JCO Precision Oncology
Open access |
Apr 2026 |
0 |
| 34 |
Unit-Dose IPPB Medications
W H Harbour · Respiratory Care
|
Feb 1974 |
0 |
| 35 |
OphthoEvidence report: Protocol for quality appraisal of clinical practice guidelines in ophthalmology
João Pedro Lima, Md. Nazmul Islam, Hamed Movahed et al. · Eye
Open access |
10 Feb 2026 |
0 |
| 36 |
MAGIC: Study Design and Rationale for the Phase 2 Clinical Trial of Faricimab for Non-Proliferative Diabetic Retinopathy
Avery Zhou et al. · Ophthalmologica
Open access |
26 Jan 2026 |
0 |
| 37 |
Updated Surgical Technique for Implantation of Revakinagene Taroretcel
Gail M. Teagle, Avery Zhou, Thomas M. Aaberg et al. · Retina
|
8 Oct 2025 |
0 |
| 38 |
RISK OF IATROGENIC PERIPHERAL RETINAL BREAKS IN 20-G PARS PLANA VITRECTOMY
G. Janzen, Elias Reichel · Evidence-Based Ophthalmology
|
Jul 2011 |
0 |
| 39 |
Patient-, caregiver-, and healthcare provider-reported burden of geographic atrophy
Sunil S. Patel, Rishi P. Singh, Jared S. Nielsen et al. · Investigative Ophthalmology & Visual Science
Open access |
23 Jun 2017 |
0 |